Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
104.46
-1.19 (-1.13%)
At close: Nov 28, 2025, 1:00 PM EST
104.00
-0.46 (-0.44%)
After-hours: Nov 28, 2025, 4:43 PM EST
Incyte Market Cap
Incyte has a market cap or net worth of $20.51 billion as of November 28, 2025. Its market cap has increased by 32.11% in one year.
Market Cap
20.51B
Enterprise Value
17.62B
1-Year Change
32.11%
Ranking
Category
Stock Price
$104.46
Market Cap Chart
Since December 1, 1998, Incyte's market cap has increased from $887.90M to $20.51B, an increase of 2,209.70%. That is a compound annual growth rate of 12.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 20.51B | 54.12% |
| Dec 31, 2024 | 13.31B | -5.44% |
| Dec 29, 2023 | 14.07B | -21.25% |
| Dec 30, 2022 | 17.87B | 10.21% |
| Dec 31, 2021 | 16.21B | -14.88% |
| Dec 31, 2020 | 19.05B | 1.27% |
| Dec 31, 2019 | 18.81B | 38.99% |
| Dec 31, 2018 | 13.53B | -32.29% |
| Dec 29, 2017 | 19.99B | 5.81% |
| Dec 30, 2016 | 18.89B | -6.36% |
| Dec 31, 2015 | 20.17B | 63.32% |
| Dec 31, 2014 | 12.35B | 51.41% |
| Dec 31, 2013 | 8.16B | 274.30% |
| Dec 31, 2012 | 2.18B | 14.96% |
| Dec 30, 2011 | 1.90B | -7.01% |
| Dec 31, 2010 | 2.04B | 88.80% |
| Dec 31, 2009 | 1.08B | 193.21% |
| Dec 31, 2008 | 368.30M | -56.50% |
| Dec 31, 2007 | 846.70M | 72.90% |
| Dec 29, 2006 | 489.70M | 9.92% |
| Dec 30, 2005 | 445.50M | -39.62% |
| Dec 31, 2004 | 737.80M | 48.87% |
| Dec 31, 2003 | 495.60M | 59.97% |
| Dec 31, 2002 | 309.80M | -76.00% |
| Dec 31, 2001 | 1.29B | -19.15% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |